The goal of the Biostatistics & Bioinformatics Shared Resource (BBSR) is to provide basic, translational, clinical and population science investigators at the Georgetown Lombardi Comprehensive Cancer Center (LCCC) with access to high-quality statistical science and informatics. Ming Tan, PhD, Chair of the Department of Biostatistics, Bioinformatics and Biomathematics (DBBB), and Subha Madhavan, PhD, Founding Director of the Georgetown Innovation Center for Biomedical Informatics (ICBI), are codirectors of the BBSR. The BBSR provides statistical and bioinformatics support for designing studies, managing and analyzing data. Its functions include study design; statistical analysis and reporting of research studies, including clinical trials, studies with high-dimensional omics and imaging data (including pathway analysis and computational modeling) and providing access to deidentified electronic health records (EHRs); review and monitoring of clinical protocols through membership on the Protocol Review and Monitoring Committee (PRMC) and the Data and Safety Monitoring Committee (DSMC); and provision of biostatistics and informatics training and expertise in collecting, integrating, managing and applying biomedical data to innovative, transdisciplinary cancer research projects. In addition, the BBSR provides LCCC investigators with advanced statistical and bioinformatics methods and expertise developed independently by BBSR faculty. The BBSR has excellent computing resources, informatics infrastructure and software necessary for efficient and effective support of LCCC research through its engagement with ICBI and the Georgetown University (Georgetown) Information Services (UIS). Through these collaborations, the BBSR focuses on Web and cloud based development for biomedical applications. It has collaborated with members in all four LCCC research programs (Breast Cancer [BC], Cancer Prevention and Control [CPC], Experimental Therapeutics [ET], and Molecular Oncology [MO]) and with multiple Shared Resources, including the Genomics & Epigenomics Shared Resource (GESR), the Survey, Recruitment & Biospecimen Collection Shared Resource (SRBSR), and the Proteomics & Metabolomics Shared Resource (PMSR) as well as the Clinical Research Management Office (CRMO). The BBSR supports the development and maintenance of standardized and scalable information architecture to connect data and metadata from clinical, biospecimen and research systems to enable all forms of cancer research. BBSR faculty members were coauthors on 156 LCCC member publications in the current funding period. During 2017, BBSR members supported 42 research projects from 25 LCCC investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA051008-27
Application #
9924508
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
27
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lee, Yichien; Rodriguez, Olga C; Albanese, Chris et al. (2018) Divergent brain changes in two audiogenic rat strains: A voxel-based morphometry and diffusion tensor imaging comparison of the genetically epilepsy prone rat (GEPR-3) and the Wistar Audiogenic Rat (WAR). Neurobiol Dis 111:80-90
Coia, Heidi; Ma, Ning; Hou, Yanqi et al. (2018) Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E. Cancer Prev Res (Phila) 11:665-676
Ory, Virginie; Kietzman, William B; Boeckelman, Jacob et al. (2018) The PPAR? agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Res Treat 169:47-57
Ozawa, Patricia Midori Murobushi; Alkhilaiwi, Faris; Cavalli, Iglenir João et al. (2018) Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells. Breast Cancer Res Treat 172:713-723
Smith, Jill P; Wang, Shangzi; Nadella, Sandeep et al. (2018) Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Cancer Immunol Immunother 67:195-207
Edwardson, Matthew A; Zhong, Xiaogang; Fiandaca, Massimo S et al. (2018) Plasma microRNA markers of upper limb recovery following human stroke. Sci Rep 8:12558
Kaat, Aaron J; Schalet, Benjamin D; Rutsohn, Joshua et al. (2018) Physical function metric over measure: An illustration with the Patient-Reported Outcomes Measurement Information System (PROMIS) and the Functional Assessment of Cancer Therapy (FACT). Cancer 124:153-160
Maximov, Philipp Y; Abderrahman, Balkees; Fanning, Sean W et al. (2018) Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer. Mol Pharmacol 94:812-822
Czarnecka, Magdalena; Lu, Congyi; Pons, Jennifer et al. (2018) Neuropeptide Y receptor interactions regulate its mitogenic activity. Neuropeptides :
Gonzalez, Thomas L; Moos, Rebecca K; Gersch, Christina L et al. (2018) Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines. Toxicol Sci 164:50-59

Showing the most recent 10 out of 1120 publications